Hydrochloric Acid

Hydrochloric Acid

SCHEMBL434986

C=CC(=O)OCC(O)C[N+](C)(C)C.[Cl-]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 2/20 0.34
CHRM1 known ✓ P11229 2/20 0.34
CHRM3 known ✓ P20309 1/20 0.33
TSHR P16473 8/20 0.57
MAPT P10636 4/20 0.44
HPGD P15428 2/20 0.41
ALDH1A1 P00352 5/20 0.41
TP53 P04637 3/20 0.41
HIF1A Q16665 3/20 0.41
CYP3A4 P08684 3/20 0.41
HSD17B10 Q99714 1/20 0.41
SLC22A16 Q86VW1 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.37
MAPK1 P28482 1/20 0.37
GALR3 O60755 1/20 0.37
BLM P54132 1/20 0.37
LMNA P02545 2/20 0.36
THRB P10828 1/20 0.35
CHRM4 P08173 2/20 0.34
TBXA2R P21731 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5672906 0.98 TSHR (0.59) TSHRMAPTHPGDALDH1A1TP53
Hydrochloric Acid SCHEMBL28204649 0.96 TSHR (0.53) TSHRMAPTHPGDALDH1A1TP53
Fluoride Ion SCHEMBL1252819 0.96 TSHR (0.57) TSHRMAPTHPGDALDH1A1TP53
Bromide SCHEMBL1254203 0.96 TSHR (0.57) TSHRMAPTHPGDALDH1A1TP53
Iodide SCHEMBL1255401 0.96 TSHR (0.57) TSHRMAPTHPGDALDH1A1TP53
Hydrochloric Acid SCHEMBL28204650 0.94 TSHR (0.55) TSHRMAPTHPGDALDH1A1TP53
SCHEMBL9505637 0.90 TSHR (0.50) TSHRMAPTHPGDALDH1A1TP53
Hydrochloric Acid SCHEMBL29254308 0.85 TSHR (0.47) TSHRMAPTHPGDALDH1A1TP53
Hydrochloric Acid SCHEMBL1255048 0.84 TSHR (0.52) TSHRMAPTHPGDALDH1A1TP53
SCHEMBL95157 0.83 TSHR (0.64) TSHRMAPTHPGDALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 448 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119472194-A Phenol-free positive photoresist stripping liquid and preparation method thereof 浙江尚能实业股份有限公司 2025-02-18 CN claimed
CN-119241935-A Antistatic PE water supply pipe and preparation method thereof 江西林基环保新科技有限公司 2025-01-03 CN claimed
CN-114907518-B Emulsifying agent for inverse emulsion polymerization and application thereof 扬州绿邦化工有限公司 2024-03-05 CN claimed
CN-114907518-A Emulsifier for inverse emulsion polymerization and application thereof 扬州绿邦化工有限公司 2022-08-16 CN claimed
CN-107746446-B Preparation method of ternary copolymerization amphoteric polyacrylamide 中国石油大学(华东) 2021-03-19 CN claimed
CN-108997535-B Early-strength polycarboxylate water reducing agent and preparation method thereof 河北三楷深发科技股份有限公司 2020-10-20 CN claimed
CN-108997535-A A kind of high-early strength type polycarboxylic acids dehydragent and preparation method thereof 河北三楷深发科技股份有限公司 2018-12-14 CN claimed
CN-107746446-A A kind of preparation method of ternary polymerization amphiprotic polyacrylamide 中国石油大学(华东) 2018-03-02 CN claimed
US-7582684-B2 Macroporous ion exchange resins 3M INNOVATIVE PROPERTIES COMPANY (US) 2009-09-01 US claimed
CN-1541136-A Use of reactive polymeric surfactants in emulsion formation 2004-10-27 CN claimed
US-12630728-B2 Ink set and recording method SEIKO EPSON CORPORATION (JP) 2026-05-19 US disclosed
US-12630582-B2 Method for biomaterial purification and kits thereof Life Technologies Corporation (US) 2026-05-19 US disclosed
US-12595400-B2 Compositions and adhesive articles including porous polymeric particles and methods of coating substrates 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-04-07 US disclosed
EP-4713521-A1 GRAFTED ARTICLES DERIVED FROM POROUS POLYMERIC FIBERS AND METHODS THEREOF 3M Innovative Properties Company (US) 2026-03-25 EP disclosed
EP-4112695-B1 TREATMENT LIQUID COMPOSITION, SET OF INK JET INK COMPOSITION AND TREATMENT LIQUID COMPOSITION, AND TREATMENT METHOD SEIKO EPSON CORP (JP) 2026-01-21 EP disclosed
EP-0171661-A1 Method of preparing cationic terpolymers and product derived therefrom AlliedSignal Inc. (US) 1986-02-19 EP disclosed
US-4360611-A BUTADIENE PREPOLYMER, EMULSION POLYMERIZATION SINLOIHI COMPANY LIMITED (JP) 1982-11-23 US disclosed
US-4314932-A Fine spherical polymer particles containing inorganic pigment and/or coloring agent and process for the preparation thereof SINLOIHI COMPANY LIMITED (JP) 1982-02-09 US disclosed
US-4269760-A SURFACES OF CATIONIC OR ANIONIC POLYMERS FORMED BY SUSPENSION POLYMERIZATION COVERED BY IONICALLY-BONDED DISPERSANTS TO EFFECT A STABILIZATION; COLOR/BLACK/; PRINTING/MECHANICAL SINLOIHI COMPANY LIMITED (JP) 1981-05-26 US disclosed
US-4163092-A QUATERNIZED MONOMER, CROSS-LINKING AGENT PLASTOMEDICAL SCIENCES, INC. (US) 1979-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630582-B2 Method for biomaterial purification and kits thereof CD68, FIBP, BMP2 CHRM2 3551/4885CHRM1 3984/4885CHRM3 3334/4885
US-12595400-B2 Compositions and adhesive articles including porous polymeric particles and methods of coating substrates ITGA1, MSR1, ILK CHRM2 142/4885CHRM1 96/4885CHRM3 532/4885
US-12630728-B2 Ink set and recording method DOT1L, SET, ALKBH3 CHRM2 470/4885CHRM1 626/4885CHRM3 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.